Journal for ImmunoTherapy of Cancer (Nov 2021)
709 Peptidyl IL-2/15Rβγc-restricted agonists, highly-attenuated and linked to anti-PD-1 antibodies to achieve selectivity and amplified potency in stimulating PD-1high lymphocytes
Abstract
No abstracts available.